Amberstone Biosciences
Latest round
- Series A
Last raised
- Nov 2021
Total raised
- $6M
Investors
- 5
About Amberstone Biosciences
Based in California, US, and founded in 2018 by CEO George Wu, Amberstone Biosciences, Inc. discovers therapeutic antibodies to treat solid tumor cancers and other diseases. In January 2022, Amberstone Biosciences, Inc. Amberstone Biosciences, Inc. develops intramural antibody programs and advances its biopharmaceutical partners’ immunotherapy pipelines. The company uses AmberFlow, a single cell platform that enables decidedly efficient isolation of antibody-drug candidates. In addition, Amberstone Biosciences, Inc. is developing immunotherapeutic pipeline assets. Amberstone Biosciences, Inc.
Who invested in Amberstone Biosciences
5 investors across 1 round
See all investors in Amberstone Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 9, 2021
Amount
$6M
Investors
Questions about Amberstone Biosciences
Who invested in Amberstone Biosciences?
Amberstone Biosciences has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amberstone Biosciences raised?
Amberstone Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Amberstone Biosciences last raise money?
Amberstone Biosciences's most recent round on record is a Series A, in Nov 2021.
What does Amberstone Biosciences do?
Based in California, US, and founded in 2018 by CEO George Wu, Amberstone Biosciences, Inc.
Where is Amberstone Biosciences headquartered?
Amberstone Biosciences is headquartered in Laguna Hills, US.
Which VCs invest in companies like Amberstone Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Amberstone Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Amberstone Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.